Clinical Trial Update: A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age [Phase 2]

View source ↗

Summary

Phase II study evaluating Luveris (lutropin alfa) in mid-follicular phase for controlled ovarian stimulation in advanced reproductive age; the trial was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Ovulation Induction

Drugs mentioned

• Luveris (lutropin alfa)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility, Ovulation Induction | Phase 2 | Status: TERMINATED | Results posted: 2013-02-20